Versant Capital Management, Inc Cara Therapeutics, Inc. Transaction History

Versant Capital Management, Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 02, 2022	BUY	$7.45 - $13.84 $409 - $761	55 New	55 $1,000
Q1 2022 Apr 29, 2022	SELL	$9.94 - $12.65 $159 - $202	-16 Closed	0 $0
Q4 2021 Jan 06, 2022	SELL	$11.99 - $18.14 $8,309 - $12,571	-693 Reduced 97.74%	16 $0
Q3 2021 Oct 29, 2021	BUY	$11.55 - $16.06 $5,532 - $7,692	479 Added 208.26%	709 $11,000
Q2 2021 Jul 22, 2021	BUY	$12.38 - $29.19 $2,847 - $6,713	230 New	230 $3,000

12.8M

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $262M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Versant Capital Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Versant Capital Management, Inc with notifications on news.